Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Cazzola

Showing results (161-170 of 802) with videos related to

Pageof 81
Sort By:
Drugs|October 16, 2013
β-Adrenoceptor modulation in chronic obstructive pulmonary disease: present and future perspectivesMaria Gabriella Matera, Luigino Calzetta, Mario Cazzola
Polish Archives of Internal Medicine|February 1, 2018
Long‑term management of patients with chronic obstructive pulmonary disease who undergo percutaneous coronary intervention still needs to be dramatically improvedMario Cazzola, Paola Rogliani, Maria G Matera
Expert Opinion on Investigational Drugs|May 29, 2014
PDE inhibitors currently in early clinical trials for the treatment of asthmaMaria Gabriella Matera, Clive Page, Mario Cazzola
Drugs|June 11, 2023
Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma?Mario Cazzola, Paola Rogliani, Maria Gabriella Matera
Pulmonary Pharmacology & Therapeutics|October 17, 2009
Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failureMaria Gabriella Matera, Eugenio Martuscelli, Mario Cazzola
Pulmonary Pharmacology & Therapeutics|December 20, 2005
Safety of inhaled corticosteroids: room for improvementGiovanni A Rossi, Franklin Cerasoli, Mario Cazzola
Respiratory Medicine|October 7, 2025
Sarcopenia as a treatable trait in COPD: From mechanisms to managementMaria Gabriella Matera, Clive Page, Mario Cazzola
Pulmonary Pharmacology & Therapeutics|January 1, 2013
Long-acting muscarinic receptor antagonists for the treatment of respiratory diseaseMario Cazzola, Clive Page, Maria Gabriella Matera
Expert Opinion on Pharmacotherapy|March 12, 2013
Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary diseaseMario Cazzola, Paola Rogliani, Maria Gabriella Matera
Expert Opinion on Pharmacotherapy|January 28, 2010
Roflumilast in chronic obstructive pulmonary disease: evidence from large trialsMario Cazzola, Stefano Picciolo, Maria G Matera
Pageof 81

Showing results (161-170 of 802) with videos related to

Sort By:
Pageof 81
Drugs|October 16, 2013
β-Adrenoceptor modulation in chronic obstructive pulmonary disease: present and future perspectivesMaria Gabriella Matera, Luigino Calzetta, Mario Cazzola
Polish Archives of Internal Medicine|February 1, 2018
Long‑term management of patients with chronic obstructive pulmonary disease who undergo percutaneous coronary intervention still needs to be dramatically improvedMario Cazzola, Paola Rogliani, Maria G Matera
Expert Opinion on Investigational Drugs|May 29, 2014
PDE inhibitors currently in early clinical trials for the treatment of asthmaMaria Gabriella Matera, Clive Page, Mario Cazzola
Drugs|June 11, 2023
Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma?Mario Cazzola, Paola Rogliani, Maria Gabriella Matera
Pulmonary Pharmacology & Therapeutics|October 17, 2009
Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failureMaria Gabriella Matera, Eugenio Martuscelli, Mario Cazzola
Pulmonary Pharmacology & Therapeutics|December 20, 2005
Safety of inhaled corticosteroids: room for improvementGiovanni A Rossi, Franklin Cerasoli, Mario Cazzola
Respiratory Medicine|October 7, 2025
Sarcopenia as a treatable trait in COPD: From mechanisms to managementMaria Gabriella Matera, Clive Page, Mario Cazzola
Pulmonary Pharmacology & Therapeutics|January 1, 2013
Long-acting muscarinic receptor antagonists for the treatment of respiratory diseaseMario Cazzola, Clive Page, Maria Gabriella Matera
Expert Opinion on Pharmacotherapy|March 12, 2013
Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary diseaseMario Cazzola, Paola Rogliani, Maria Gabriella Matera
Expert Opinion on Pharmacotherapy|January 28, 2010
Roflumilast in chronic obstructive pulmonary disease: evidence from large trialsMario Cazzola, Stefano Picciolo, Maria G Matera
Pageof 81